Oct 11, 2021 12:57 PM IST
Studies show that close to 2.5 million people suffer from COPD in Spain.
- Oct 03, 2021 12:18 PM IST
As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Glenmark's US-based unit is recalling various products in the US market.
- Jul 09, 2021 12:23 PM IST
The approved product is therapeutically equivalent to the reference listed drug product Tarceva tablets of OSI Pharmaceuticals, LLC.
- Jun 08, 2021 09:46 AM IST
The FDA approved Aduhelm for the treatment of Alzheimer's disease. The decision did not define the patient population for whom the treatment is appropriate.
- Jun 06, 2021 01:41 PM IST
Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.
- Mar 06, 2021 01:25 PM IST
"The secondary objective findings in this study, of a quicker decrease in infectious virus among individuals with early COVID-19 treated with molnupiravir, are promising," said William Fischer, Associate Professor of Medicine at the University of North Carolina School of Medicine, in a statement from the companies.
- May 27, 2020 10:59 AM IST
Glenmark Pharmaceuticals Inc, USA has been granted final approval by the US Food and Drug Administration (USFDA) for Chlorzoxazone tablets USP, in strength of 375 mg and 750 mg, the drug maker said in a statement.
- May 19, 2020 01:15 PM IST
The company has launched of authorised generic version of Bausch Health's Apriso (Mesalamine extended-release capsules 0.375 g) in the US, Lupin said in a statement.
- Apr 27, 2020 01:44 PM IST
The company's tablets are available in 54 mg dose in bottle count size of 90, and 160 mg dose in bottle count sizes of 90 and 500
- Apr 20, 2020 12:56 PM IST
Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market Alcaftadine ophthalmic solution, in the American market.
- Apr 16, 2020 11:12 AM IST
Remdesivir, which is yet to get regulatory approval, has improved the condition of 36 critically ill COVID-19 patients in a multi-country compassionate use programme.
- Apr 10, 2020 07:41 PM IST
Despite limited clinical evidence, HCQ is now used by many countries for treating COVID-19 patients.
- Mar 20, 2020 10:51 AM IST
The study tested Kaletra, a combination of two antiviral medicines, lopinavir and ritonavir, that are normally used to treat HIV
- Feb 15, 2020 06:40 PM IST
Drug abuse among youngsters was painful, Vijayan said and wanted people to extend support to the police and excise departments in curbing the menace.
- Dec 07, 2019 03:30 PM IST
Talking to reporters, GFP MLA Vinod Paliencar said he submitted the report to Modi last week.
- Oct 21, 2019 12:42 PM IST
The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the London-listed company said, and follows a similar approval by the European authorities in August.
- Jul 17, 2019 07:57 PM IST
Suven had planned to release the study's top-line data at the Alzheimer's Association International Conference (AAIC) in Los Angeles on July 17, but this has now been delayed due to technical reasons
- May 21, 2019 11:15 AM IST
The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg, Alembic Pharmaceuticals said in a BSE filing.
- Mar 13, 2019 12:33 PM IST
The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 8 mEq (600 mg) and 10 mEq (750 mg), Zydus Cadila said in a BSE filing.
- Dec 24, 2018 11:22 AM IST
Strides Pharma Global, Singapore, has received approval for Polyethylene Glycol 3350 and Electrolytes for Oral Solution USP in the strengths of 236 grams/2.97 grams/6.74 grams/5.86 grams/22.74 grams/4 Liter from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a filing to BSE.
- Dec 04, 2018 11:07 AM IST
The company's wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate tablets USP in the strengths of 1 mg and 2mg, Alembic Pharmaceuticals said in a BSE filing.
- Nov 28, 2018 11:19 AM IST
Dr Reddy's Laboratories Ltd launched Chlorthalidone tablets USP in the strengths of 25 mg and 50 mg, a therapeutic equivalent generic version of Hygroton tablets, Dr Reddy's Laboratories said in a BSE filing.
- Nov 01, 2018 02:20 PM IST
The company has launched the tablets in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg in the US market after receiving the final approval from the United States Food and Drug Adminstration (USFDA), Zydus Cadila said in a statement.
- Oct 31, 2018 01:52 PM IST
The company said it had submitted a detailed compliance report to the US Food and Drug Administration (USFDA) within the stipulated period in response to the Form 483 containing eight observations issued to it by the regulator.
- Oct 05, 2018 12:50 PM IST
The company has received approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 25 mg, Zydus Cadila said in a BSE filing.